Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement
- PMID: 1245741
Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement
Abstract
The use of a serum-free environment and target cells carrying defined amounts of radiolabeled antigen allowed a quantitative study of the role of antigen, antibody, and complement on antibody-mediated cell cytotoxicity (AbMC). For lysis to occure, a minimum number of antigen molecules must be present on the target cell. 51Cr release from target cells with lower antigen density requires larger concentration of effector cells and antibodies. Target cell-bound complement, itself unable to mediate cytotoxicity, reduces the number of IgG molecules required for lysis. The antibody and complement, however, have to be bound to the same target cell. Bystander complement-coated erythrocytes, present in the same reaction mixture with IgG-coated targets, are not lysed. Blocking of AbMC is effected only by antigen, either soluble or in immune complexes prepared in antigen excess. Antigen competes at the level of the target cell. Blocking at the level of the effector cell, by use of immune complexes prepared at equivalence or in antibody excess, is difficult to achieve. The large number of cells with Fc receptors contained in mouse spleens may explain this finding. Arming of effector cells by passive binding of immune complexes is poorly effective as a means of obtaining lysis of the target cells. In all situations, the outcome of the reaction is determined by the presence of free antibody-combining sites, alone, or in immune complexes, that are able to combine with the target cell membrane antigen. The requirements for lysis are rather stringent.
Similar articles
-
Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.Ann Immunol (Paris). 1981 Jul-Aug;132D(1):3-14. Ann Immunol (Paris). 1981. PMID: 7347555
-
Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.Clin Exp Immunol. 1979 Oct;38(1):158-65. Clin Exp Immunol. 1979. PMID: 316751 Free PMC article.
-
Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors.J Immunol. 1975 Nov;115(5):1223-6. J Immunol. 1975. PMID: 1176774
-
Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.Crit Rev Immunol. 1981 Jan;1(3):165-209. Crit Rev Immunol. 1981. PMID: 6174273 Review.
-
Interaction of Fc and C3 receptors of lymphoid cells with antibodies against products of the major histocompatibility complex: association of MHC products with complement receptors.Transplant Rev. 1976;30:140-73. Transplant Rev. 1976. PMID: 59971 Review. No abstract available.
Cited by
-
Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement.Infect Immun. 1977 Dec;18(3):660-5. doi: 10.1128/iai.18.3.660-665.1977. Infect Immun. 1977. PMID: 201564 Free PMC article.
-
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma.Cancer Immunol Immunother. 2022 May;71(5):1017-1031. doi: 10.1007/s00262-021-03054-8. Epub 2021 Sep 20. Cancer Immunol Immunother. 2022. PMID: 34545416 Free PMC article.
-
Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.J Exp Med. 1978 Apr 1;147(4):973-83. doi: 10.1084/jem.147.4.973. J Exp Med. 1978. PMID: 206648 Free PMC article.
-
Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.Clin Exp Immunol. 1979 Jun;36(3):397-407. Clin Exp Immunol. 1979. PMID: 487643 Free PMC article.
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition).Eur J Immunol. 2019 Oct;49(10):1457-1973. doi: 10.1002/eji.201970107. Eur J Immunol. 2019. PMID: 31633216 Free PMC article.